Search - tctmd.com

Displaying 1 - 20 of 1101

Sort: Relevancy | Date

Presentation AHA 2016

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

Presentation AHA 2016

FUnctional Testing Underlying REvascularization: The FUTURE trial

Presenter: Gilles Rioufol

November 15, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

To Pretreat or Not to Pretreat? The DUBIUS Trial

Presenter: Roxana Mehran, Ferdinando Varbella, Giuseppe Tarantini

November 01, 2016

Presentation TCT 2016

Case Introduction: An Elderly Patient With NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

Presentation TCT 2016

Case Presentation: ACS Intervention in the Emerging BRS Era

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Evgeny V. Merkulov

November 01, 2016

Presentation TCT 2016

Delivery System and Therapeutic Challenges and Opportunities in Africa

Presenter: Graham A. Cassel, Harun A Otieno

November 01, 2016

Presentation TCT 2016

Diagnosis and Treatment of Erosion in ACS: The EROSION Study

Presenter: John A. Ambrose, Peter H. Stone, Ik-Kyung Jang

November 01, 2016

Presentation TCT 2016

ACS and Pharmacotherapy Guidelines Update

Presenter: George D. Dangas, Debabrata Mukherjee, John A. Bittl

November 01, 2016

Presentation TCT 2016

PICSO to Improve Myocardial Salvage and Reduce Infarct Size in STEMI: Emerging Data

Presenter: Cindy L. Grines, Holger Thiele, Azfar G. Zaman

October 31, 2016

Presentation TCT 2016

Benefit of Supersaturated Oxygen for Large Anterior STEMI: From ICI-HOT to Approval?

Presenter: Cindy L. Grines, Holger Thiele, Gregg W. Stone

October 31, 2016

Presentation TCT 2016

Establishing ECMO in the Severe Shock and Cardiac Arrest Patient: Practical Issues and Patient Outcomes

Presenter: Cindy L. Grines, Holger Thiele, Hiroo Takayama

October 31, 2016

Presentation TCT 2016

Outcomes of Impella in 347 Patients With Cardiogenic Shock: The US Impella Registry

Presenter: Cindy L. Grines, Holger Thiele, William W. O'Neill

October 31, 2016

Presentation TCT 2016

Pharmacoinvasive Strategy for Treating Acute MI: Is It The Way Forward in India?

Presenter: Vinay K. Bahl, Amal Kumar Banerjee, Jamshed J. Dalal, Narenda N. Khanna, Ajay J. Kirtane, C. Venkata S. Ram, Kamal K. Sethi, Sreenivas Arramraju Kumar

October 31, 2016

Presentation TCT 2016

TOTAL Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Francesco Burzotta

October 31, 2016

Presentation TCT 2016

Support for Hemodynamically Severe RV Infarction: When to Use Impella RP, TandemHeart, and/or CentriMag

Presenter: Cindy L. Grines, Holger Thiele, A. Reshad Garan

October 31, 2016

Advertisement

Arterial Revascularization Trial (ART)

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

FUnctional Testing Underlying REvascularization: The FUTURE trial

Case Conclusion: How Did We Treat Our Patient?

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Case Conclusion: How Did We Treat Our Patient?

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

To Pretreat or Not to Pretreat? The DUBIUS Trial

Case Introduction: An Elderly Patient With NSTE-ACS

Case Presentation: ACS Intervention in the Emerging BRS Era

Delivery System and Therapeutic Challenges and Opportunities in Africa

Diagnosis and Treatment of Erosion in ACS: The EROSION Study

ACS and Pharmacotherapy Guidelines Update

PICSO to Improve Myocardial Salvage and Reduce Infarct Size in STEMI: Emerging Data

Benefit of Supersaturated Oxygen for Large Anterior STEMI: From ICI-HOT to Approval?

Establishing ECMO in the Severe Shock and Cardiac Arrest Patient: Practical Issues and Patient Outcomes

Outcomes of Impella in 347 Patients With Cardiogenic Shock: The US Impella Registry

Pharmacoinvasive Strategy for Treating Acute MI: Is It The Way Forward in India?

TOTAL Critique: Pros and Cons

Support for Hemodynamically Severe RV Infarction: When to Use Impella RP, TandemHeart, and/or CentriMag

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content